Miyasaka et al. demonstrated that the PI3K/mTOR pathway inhibition could overcome radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer and targeting the PI3K/mTOR or HIF-1α pathways could improve radiosensitivity29. This evidence concerns the gene MTOR and endometrial cancer.